521 related articles for article (PubMed ID: 17678918)
21. The therapeutic effect of glatiramer acetate in a murine model of inflammatory bowel disease is mediated by anti-inflammatory T-cells.
Aharoni R; Sonego H; Brenner O; Eilam R; Arnon R
Immunol Lett; 2007 Oct; 112(2):110-9. PubMed ID: 17719654
[TBL] [Abstract][Full Text] [Related]
22. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis.
Fukata M; Michelsen KS; Eri R; Thomas LS; Hu B; Lukasek K; Nast CC; Lechago J; Xu R; Naiki Y; Soliman A; Arditi M; Abreu MT
Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1055-65. PubMed ID: 15826931
[TBL] [Abstract][Full Text] [Related]
23. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
Gonzalez-Rey E; Delgado M
Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
[TBL] [Abstract][Full Text] [Related]
25. Adiponectin deficiency protects mice from chemically induced colonic inflammation.
Fayad R; Pini M; Sennello JA; Cabay RJ; Chan L; Xu A; Fantuzzi G
Gastroenterology; 2007 Feb; 132(2):601-14. PubMed ID: 17258715
[TBL] [Abstract][Full Text] [Related]
26. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
[TBL] [Abstract][Full Text] [Related]
27. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
Steidler L; Hans W; Schotte L; Neirynck S; Obermeier F; Falk W; Fiers W; Remaut E
Science; 2000 Aug; 289(5483):1352-5. PubMed ID: 10958782
[TBL] [Abstract][Full Text] [Related]
28. Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice.
Elinav E; Waks T; Eshhar Z
Gastroenterology; 2008 Jun; 134(7):2014-24. PubMed ID: 18424268
[TBL] [Abstract][Full Text] [Related]
29. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
[TBL] [Abstract][Full Text] [Related]
30. A hypervariable N-terminal region of Yersinia LcrV determines Toll-like receptor 2-mediated IL-10 induction and mouse virulence.
Sing A; Reithmeier-Rost D; Granfors K; Hill J; Roggenkamp A; Heesemann J
Proc Natl Acad Sci U S A; 2005 Nov; 102(44):16049-54. PubMed ID: 16239347
[TBL] [Abstract][Full Text] [Related]
31. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation.
Melgar S; Karlsson A; Michaëlsson E
Am J Physiol Gastrointest Liver Physiol; 2005 Jun; 288(6):G1328-38. PubMed ID: 15637179
[TBL] [Abstract][Full Text] [Related]
32. Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.
Shigemori S; Watanabe T; Kudoh K; Ihara M; Nigar S; Yamamoto Y; Suda Y; Sato T; Kitazawa H; Shimosato T
Microb Cell Fact; 2015 Nov; 14():189. PubMed ID: 26608030
[TBL] [Abstract][Full Text] [Related]
33. Reactivation of inflammatory bowel disease in a mouse model of depression.
Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
[TBL] [Abstract][Full Text] [Related]
34. Targeting delivery of anti-TNFalpha oligonucleotide into activated colonic macrophages protects against experimental colitis.
Zuo L; Huang Z; Dong L; Xu L; Zhu Y; Zeng K; Zhang C; Chen J; Zhang J
Gut; 2010 Apr; 59(4):470-9. PubMed ID: 19951904
[TBL] [Abstract][Full Text] [Related]
35. AMPK agonist downregulates innate and adaptive immune responses in TNBS-induced murine acute and relapsing colitis.
Bai A; Ma AG; Yong M; Weiss CR; Ma Y; Guan Q; Bernstein CN; Peng Z
Biochem Pharmacol; 2010 Dec; 80(11):1708-17. PubMed ID: 20797389
[TBL] [Abstract][Full Text] [Related]
36. CpG motifs of bacterial DNA essentially contribute to the perpetuation of chronic intestinal inflammation.
Obermeier F; Dunger N; Strauch UG; Hofmann C; Bleich A; Grunwald N; Hedrich HJ; Aschenbrenner E; Schlegelberger B; Rogler G; Schölmerich J; Falk W
Gastroenterology; 2005 Sep; 129(3):913-27. PubMed ID: 16143131
[TBL] [Abstract][Full Text] [Related]
37. DA-6034, a derivative of flavonoid, prevents and ameliorates dextran sulfate sodium-induced colitis and inhibits colon carcinogenesis.
Nam SY; Kim JS; Kim JM; Lee JY; Kim N; Jung HC; Song IS
Exp Biol Med (Maywood); 2008 Feb; 233(2):180-91. PubMed ID: 18222973
[TBL] [Abstract][Full Text] [Related]
38. Yersinia V antigen induces both TLR homo- and heterotolerance in an IL-10-involving manner.
Reithmeier-Rost D; Bierschenk S; Filippova N; Schröder-Braunstein J; Sing A
Cell Immunol; 2004; 231(1-2):63-74. PubMed ID: 15919371
[TBL] [Abstract][Full Text] [Related]
39. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease.
Nakase H; Okazaki K; Tabata Y; Chiba T
J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874
[TBL] [Abstract][Full Text] [Related]
40. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
Bhatia M; Landolfi C; Basta F; Bovi G; Ramnath RD; de Joannon AC; Guglielmotti A
Inflamm Res; 2008 Oct; 57(10):464-71. PubMed ID: 18827968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
